Welcome to the homepage of the U.S. Department of Defense (DoD) Pharmacy & Therapeutics (P&T) Committee

If you would like to be notified by email when this page is updated, click here.

If you subscribe to this committee webpage, you will receive updates by the Beneficiary Advisory Panel as well as the Department of Defense Pharmacy and Therapeutics Committee.

Minutes from the quarterly meetings of the DoD P&T Committee are available below. Please note that files for the July 2004 and subsequent meetings
contain both meeting minutes and the decision paper signed by the Director, TRICARE Management Activity, approving or disapproving the
recommendations of the Committee. The July 2004 meeting marked the first meeting under the new
DoD P&T Committee charter, which established a
new membership structure and approval authority. For more information about the DoD P&T Committee's role in managing DoD formularies, please
see the Dec 2004 Health Affairs Policy 04-032, TRICARE Pharmacy Benefit
Formulary Management (clarified 22 Mar 2005).